APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Conjugates Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peptide Conjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026194 pages

Choose your research edition.

Industry ResearchPeptide Conjugates Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Conjugates Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Peptide Conjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Conjugates Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Conjugates Service Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Peptide Conjugates Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide Conjugates Service include Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON and SBS Genetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peptide Conjugates Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide Conjugates Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide Conjugates Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide Conjugates Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide Conjugates Service Segment by Company

Almac Group

Bio-Synthesis

Creative Peptides

ProtaGene GmbH

WuXi TIDES

Medtide Inc

Ajinomoto

PHARMARON

SBS Genetech

Creative Enzymes

AnaSpec

BOCSCI Inc

JPT Peptide Technologies

Kaneka Eurogentec SA

QYAOBIO

Peptide Conjugates Service Segment by Type

Peptide Oligonucleotide Conjugates

Peptide Carrier Protein Conjugates

Peptide Small Molecule Conjugates

Other

Peptide Conjugates Service Segment by Application

Vaccine Development

Drug Delivery

Biomarkers

Peptide Conjugates Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Conjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Conjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Conjugates Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide Conjugates Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Conjugates Service industry.

Chapter 3: Detailed analysis of Peptide Conjugates Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Conjugates Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Conjugates Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Peptide Oligonucleotide Conjugates Table 3. Key Players of Peptide Carrier Protein Conjugates Table 4. Key Players of Peptide Small Molecule Conjugates Table 3. Key Players of Other Table 4. Global Peptide Conjugates Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Vaccine Development Table 6. Key Players of Drug Delivery Table 7. Key Players of Biomarkers Table 8. Global Peptide Conjugates Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Peptide Conjugates Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Peptide Conjugates Service Market Share by Region (2021-2026) Table 11. Global Peptide Conjugates Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Peptide Conjugates Service Market Share by Region (2027-2032) Table 13. Peptide Conjugates Service Industry Trends Table 14. Peptide Conjugates Service Industry Drivers Table 15. Peptide Conjugates Service Industry Opportunities and Challenges Table 16. Peptide Conjugates Service Industry Restraints Table 17. Global Peptide Conjugates Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Peptide Conjugates Service Revenue Market Share by Company (2021-2026) Table 19. Global Peptide Conjugates Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Peptide Conjugates Service Key Company Head Office and Area Served Table 21. Global Peptide Conjugates Service Company, Product Type & Application Table 22. Global Peptide Conjugates Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Peptide Conjugates Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Peptide Conjugates Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Peptide Conjugates Service Revenue Market Share by Type (2021-2026) Table 29. Global Peptide Conjugates Service Revenue Market Share by Type (2027-2032) Table 30. Global Peptide Conjugates Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Peptide Conjugates Service Revenue Market Share by Application (2021-2026) Table 34. Global Peptide Conjugates Service Revenue Market Share by Application (2027-2032) Table 35. Almac Group Company Information Table 36. Almac Group Business Overview Table 37. Almac Group Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Almac Group Peptide Conjugates Service Product Portfolio Table 39. Almac Group Recent Development Table 40. Bio-Synthesis Company Information Table 41. Bio-Synthesis Business Overview Table 42. Bio-Synthesis Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bio-Synthesis Peptide Conjugates Service Product Portfolio Table 44. Bio-Synthesis Recent Development Table 45. Creative Peptides Company Information Table 46. Creative Peptides Business Overview Table 47. Creative Peptides Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Creative Peptides Peptide Conjugates Service Product Portfolio Table 49. Creative Peptides Recent Development Table 50. ProtaGene GmbH Company Information Table 51. ProtaGene GmbH Business Overview Table 52. ProtaGene GmbH Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ProtaGene GmbH Peptide Conjugates Service Product Portfolio Table 54. ProtaGene GmbH Recent Development Table 55. WuXi TIDES Company Information Table 56. WuXi TIDES Business Overview Table 57. WuXi TIDES Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. WuXi TIDES Peptide Conjugates Service Product Portfolio Table 59. WuXi TIDES Recent Development Table 60. Medtide Inc Company Information Table 61. Medtide Inc Business Overview Table 62. Medtide Inc Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Medtide Inc Peptide Conjugates Service Product Portfolio Table 64. Medtide Inc Recent Development Table 65. Ajinomoto Company Information Table 66. Ajinomoto Business Overview Table 67. Ajinomoto Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ajinomoto Peptide Conjugates Service Product Portfolio Table 69. Ajinomoto Recent Development Table 70. PHARMARON Company Information Table 71. PHARMARON Business Overview Table 72. PHARMARON Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. PHARMARON Peptide Conjugates Service Product Portfolio Table 74. PHARMARON Recent Development Table 75. SBS Genetech Company Information Table 76. SBS Genetech Business Overview Table 77. SBS Genetech Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. SBS Genetech Peptide Conjugates Service Product Portfolio Table 79. SBS Genetech Recent Development Table 80. Creative Enzymes Company Information Table 81. Creative Enzymes Business Overview Table 82. Creative Enzymes Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Creative Enzymes Peptide Conjugates Service Product Portfolio Table 84. Creative Enzymes Recent Development Table 85. AnaSpec Company Information Table 86. AnaSpec Business Overview Table 87. AnaSpec Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. AnaSpec Peptide Conjugates Service Product Portfolio Table 89. AnaSpec Recent Development Table 90. BOCSCI Inc Company Information Table 91. BOCSCI Inc Business Overview Table 92. BOCSCI Inc Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. BOCSCI Inc Peptide Conjugates Service Product Portfolio Table 94. BOCSCI Inc Recent Development Table 95. JPT Peptide Technologies Company Information Table 96. JPT Peptide Technologies Business Overview Table 97. JPT Peptide Technologies Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. JPT Peptide Technologies Peptide Conjugates Service Product Portfolio Table 99. JPT Peptide Technologies Recent Development Table 100. Kaneka Eurogentec SA Company Information Table 101. Kaneka Eurogentec SA Business Overview Table 102. Kaneka Eurogentec SA Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Kaneka Eurogentec SA Peptide Conjugates Service Product Portfolio Table 104. Kaneka Eurogentec SA Recent Development Table 105. QYAOBIO Company Information Table 106. QYAOBIO Business Overview Table 107. QYAOBIO Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. QYAOBIO Peptide Conjugates Service Product Portfolio Table 109. QYAOBIO Recent Development Table 110. North America Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 111. North America Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 112. North America Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 113. North America Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 114. North America Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Peptide Conjugates Service Market Size by Country (2021-2026) Table 116. North America Peptide Conjugates Service Market Size by Country (2027-2032) Table 117. Europe Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 118. Europe Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 119. Europe Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 120. Europe Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 121. Europe Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Peptide Conjugates Service Market Size by Country (2021-2026) Table 123. Europe Peptide Conjugates Service Market Size by Country (2027-2032) Table 124. China Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 125. China Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 126. China Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 127. China Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 129. Asia Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 130. Asia Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 131. Asia Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Peptide Conjugates Service Market Size by Country (2021-2026) Table 134. Asia Peptide Conjugates Service Market Size by Country (2027-2032) Table 135. South America, Middle East & Africa Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 136. South America, Middle East & Africa Peptide Conjugates Service Market Size by Type (2027-2032) & (US$ Million) Table 137. South America, Middle East & Africa Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 138. South America, Middle East & Africa Peptide Conjugates Service Market Size by Application (2027-2032) & (US$ Million) Table 139. South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2021-2026) Table 141. South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Peptide Conjugates Service Product Image Figure 2. Global Peptide Conjugates Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptide Conjugates Service Market Share by Type: 2025 VS 2032 Figure 4. Peptide Oligonucleotide Conjugates Image Figure 5. Peptide Carrier Protein Conjugates Image Figure 6. Peptide Small Molecule Conjugates Image Figure 7. Other Image Figure 8. Global Peptide Conjugates Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Peptide Conjugates Service Market Share by Application: 2025 VS 2032 Figure 10. Vaccine Development Image Figure 11. Drug Delivery Image Figure 12. Biomarkers Image Figure 13. Global Peptide Conjugates Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 15. Global Peptide Conjugates Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Peptide Conjugates Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Peptide Conjugates Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peptide Conjugates Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peptide Conjugates Service Revenue Market Share by Type (2021-2032) Figure 22. Global Peptide Conjugates Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Peptide Conjugates Service Revenue Market Share by Application (2021-2032) Figure 24. North America Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 25. North America Peptide Conjugates Service Market Share by Type (2021-2032) Figure 26. North America Peptide Conjugates Service Market Share by Application (2021-2032) Figure 27. North America Peptide Conjugates Service Market Share by Country (2021-2032) Figure 28. United States Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Peptide Conjugates Service Market Share by Type (2021-2032) Figure 33. Europe Peptide Conjugates Service Market Share by Application (2021-2032) Figure 34. Europe Peptide Conjugates Service Market Share by Country (2021-2032) Figure 35. Germany Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 36. France Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 41. China Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 42. China Peptide Conjugates Service Market Share by Type (2021-2032) Figure 43. China Peptide Conjugates Service Market Share by Application (2021-2032) Figure 44. Asia Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia Peptide Conjugates Service Market Share by Type (2021-2032) Figure 46. Asia Peptide Conjugates Service Market Share by Application (2021-2032) Figure 47. Asia Peptide Conjugates Service Market Share by Country (2021-2032) Figure 48. Japan Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 52. India Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Peptide Conjugates Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Peptide Conjugates Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Peptide Conjugates Service Market Share by Country (2021-2032) Figure 58. Brazil Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Peptide Oligonucleotide Conjugates
  • Peptide Carrier Protein Conjugates
  • Peptide Small Molecule Conjugates
  • Other
Applications
  • Vaccine Development
  • Drug Delivery
  • Biomarkers
Companies covered
  • Almac Group
  • Bio-Synthesis
  • Creative Peptides
  • ProtaGene GmbH
  • WuXi TIDES
  • Medtide Inc
  • Ajinomoto
  • PHARMARON
  • SBS Genetech
  • Creative Enzymes
  • AnaSpec
  • BOCSCI Inc
  • JPT Peptide Technologies
  • Kaneka Eurogentec SA
  • QYAOBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptide Conjugates Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Peptide Oligonucleotide Conjugates
  5. 1.2.3 Peptide Carrier Protein Conjugates
  6. 1.2.4 Peptide Small Molecule Conjugates
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Peptide Conjugates Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Vaccine Development
  11. 1.3.3 Drug Delivery
  12. 1.3.4 Biomarkers
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Peptide Conjugates Service Growth Trends by Region
  15. 1.5.1 Global Peptide Conjugates Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Peptide Conjugates Service Market Size by Region (2021-2026)
  17. 1.5.3 Peptide Conjugates Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Peptide Conjugates Service Market Dynamics
  1. 2.1 Peptide Conjugates Service Industry Trends
  2. 2.2 Peptide Conjugates Service Industry Drivers
  3. 2.3 Peptide Conjugates Service Industry Opportunities and Challenges
  4. 2.4 Peptide Conjugates Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptide Conjugates Service Revenue by Company (2021-2026)
  2. 3.2 Global Peptide Conjugates Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptide Conjugates Service Key Company Head office and Area Served
  4. 3.4 Global Peptide Conjugates Service Company, Product Type & Application
  5. 3.5 Global Peptide Conjugates Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptide Conjugates Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptide Conjugates Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptide Conjugates Service Tier 1, Tier 2, and Tier 3
4 Peptide Conjugates Service Market by Type
  1. 4.1 Global Peptide Conjugates Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptide Conjugates Service Market Size by Type (2021-2032)
  3. 4.3 Global Peptide Conjugates Service Market Size Share by Type (2021-2032)
5 Peptide Conjugates Service Market by Application
  1. 5.1 Global Peptide Conjugates Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide Conjugates Service Market Size by Application (2021-2032)
  3. 5.3 Global Peptide Conjugates Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Almac Group
  2. 6.1.1 Almac Group Company Information
  3. 6.1.2 Almac Group Business Overview
  4. 6.1.3 Almac Group Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Almac Group Peptide Conjugates Service Product Portfolio
  6. 6.1.5 Almac Group Recent Developments
  7. 6.2 Bio-Synthesis
  8. 6.2.1 Bio-Synthesis Company Information
  9. 6.2.2 Bio-Synthesis Business Overview
  10. 6.2.3 Bio-Synthesis Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bio-Synthesis Peptide Conjugates Service Product Portfolio
  12. 6.2.5 Bio-Synthesis Recent Developments
  13. 6.3 Creative Peptides
  14. 6.3.1 Creative Peptides Company Information
  15. 6.3.2 Creative Peptides Business Overview
  16. 6.3.3 Creative Peptides Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Creative Peptides Peptide Conjugates Service Product Portfolio
  18. 6.3.5 Creative Peptides Recent Developments
  19. 6.4 ProtaGene GmbH
  20. 6.4.1 ProtaGene GmbH Company Information
  21. 6.4.2 ProtaGene GmbH Business Overview
  22. 6.4.3 ProtaGene GmbH Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ProtaGene GmbH Peptide Conjugates Service Product Portfolio
  24. 6.4.5 ProtaGene GmbH Recent Developments
  25. 6.5 WuXi TIDES
  26. 6.5.1 WuXi TIDES Company Information
  27. 6.5.2 WuXi TIDES Business Overview
  28. 6.5.3 WuXi TIDES Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi TIDES Peptide Conjugates Service Product Portfolio
  30. 6.5.5 WuXi TIDES Recent Developments
  31. 6.6 Medtide Inc
  32. 6.6.1 Medtide Inc Company Information
  33. 6.6.2 Medtide Inc Business Overview
  34. 6.6.3 Medtide Inc Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Medtide Inc Peptide Conjugates Service Product Portfolio
  36. 6.6.5 Medtide Inc Recent Developments
  37. 6.7 Ajinomoto
  38. 6.7.1 Ajinomoto Company Information
  39. 6.7.2 Ajinomoto Business Overview
  40. 6.7.3 Ajinomoto Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ajinomoto Peptide Conjugates Service Product Portfolio
  42. 6.7.5 Ajinomoto Recent Developments
  43. 6.8 PHARMARON
  44. 6.8.1 PHARMARON Company Information
  45. 6.8.2 PHARMARON Business Overview
  46. 6.8.3 PHARMARON Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 PHARMARON Peptide Conjugates Service Product Portfolio
  48. 6.8.5 PHARMARON Recent Developments
  49. 6.9 SBS Genetech
  50. 6.9.1 SBS Genetech Company Information
  51. 6.9.2 SBS Genetech Business Overview
  52. 6.9.3 SBS Genetech Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 SBS Genetech Peptide Conjugates Service Product Portfolio
  54. 6.9.5 SBS Genetech Recent Developments
  55. 6.10 Creative Enzymes
  56. 6.10.1 Creative Enzymes Company Information
  57. 6.10.2 Creative Enzymes Business Overview
  58. 6.10.3 Creative Enzymes Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Creative Enzymes Peptide Conjugates Service Product Portfolio
  60. 6.10.5 Creative Enzymes Recent Developments
  61. 6.11 AnaSpec
  62. 6.11.1 AnaSpec Company Information
  63. 6.11.2 AnaSpec Business Overview
  64. 6.11.3 AnaSpec Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 AnaSpec Peptide Conjugates Service Product Portfolio
  66. 6.11.5 AnaSpec Recent Developments
  67. 6.12 BOCSCI Inc
  68. 6.12.1 BOCSCI Inc Company Information
  69. 6.12.2 BOCSCI Inc Business Overview
  70. 6.12.3 BOCSCI Inc Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 BOCSCI Inc Peptide Conjugates Service Product Portfolio
  72. 6.12.5 BOCSCI Inc Recent Developments
  73. 6.13 JPT Peptide Technologies
  74. 6.13.1 JPT Peptide Technologies Company Information
  75. 6.13.2 JPT Peptide Technologies Business Overview
  76. 6.13.3 JPT Peptide Technologies Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 JPT Peptide Technologies Peptide Conjugates Service Product Portfolio
  78. 6.13.5 JPT Peptide Technologies Recent Developments
  79. 6.14 Kaneka Eurogentec SA
  80. 6.14.1 Kaneka Eurogentec SA Company Information
  81. 6.14.2 Kaneka Eurogentec SA Business Overview
  82. 6.14.3 Kaneka Eurogentec SA Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Kaneka Eurogentec SA Peptide Conjugates Service Product Portfolio
  84. 6.14.5 Kaneka Eurogentec SA Recent Developments
  85. 6.15 QYAOBIO
  86. 6.15.1 QYAOBIO Company Information
  87. 6.15.2 QYAOBIO Business Overview
  88. 6.15.3 QYAOBIO Peptide Conjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 QYAOBIO Peptide Conjugates Service Product Portfolio
  90. 6.15.5 QYAOBIO Recent Developments
7 North America
  1. 7.1 North America Peptide Conjugates Service Market Size (2021-2032)
  2. 7.2 North America Peptide Conjugates Service Market Size by Type
  3. 7.2.1 North America Peptide Conjugates Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptide Conjugates Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptide Conjugates Service Market Share by Type (2021-2032)
  6. 7.3 North America Peptide Conjugates Service Market Size by Application
  7. 7.3.1 North America Peptide Conjugates Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptide Conjugates Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptide Conjugates Service Market Share by Application (2021-2032)
  10. 7.4 North America Peptide Conjugates Service Market Size by Country
  11. 7.4.1 North America Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptide Conjugates Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptide Conjugates Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptide Conjugates Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptide Conjugates Service Market Size (2021-2032)
  2. 8.2 Europe Peptide Conjugates Service Market Size by Type
  3. 8.2.1 Europe Peptide Conjugates Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptide Conjugates Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptide Conjugates Service Market Share by Type (2021-2032)
  6. 8.3 Europe Peptide Conjugates Service Market Size by Application
  7. 8.3.1 Europe Peptide Conjugates Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptide Conjugates Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptide Conjugates Service Market Share by Application (2021-2032)
  10. 8.4 Europe Peptide Conjugates Service Market Size by Country
  11. 8.4.1 Europe Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptide Conjugates Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptide Conjugates Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptide Conjugates Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptide Conjugates Service Market Size (2021-2032)
  2. 9.2 China Peptide Conjugates Service Market Size by Type
  3. 9.2.1 China Peptide Conjugates Service Market Size by Type (2021-2026)
  4. 9.2.2 China Peptide Conjugates Service Market Size by Type (2027-2032)
  5. 9.2.3 China Peptide Conjugates Service Market Share by Type (2021-2032)
  6. 9.3 China Peptide Conjugates Service Market Size by Application
  7. 9.3.1 China Peptide Conjugates Service Market Size by Application (2021-2026)
  8. 9.3.2 China Peptide Conjugates Service Market Size by Application (2027-2032)
  9. 9.3.3 China Peptide Conjugates Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptide Conjugates Service Market Size (2021-2032)
  2. 10.2 Asia Peptide Conjugates Service Market Size by Type
  3. 10.2.1 Asia Peptide Conjugates Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptide Conjugates Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptide Conjugates Service Market Share by Type (2021-2032)
  6. 10.3 Asia Peptide Conjugates Service Market Size by Application
  7. 10.3.1 Asia Peptide Conjugates Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptide Conjugates Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptide Conjugates Service Market Share by Application (2021-2032)
  10. 10.4 Asia Peptide Conjugates Service Market Size by Country
  11. 10.4.1 Asia Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptide Conjugates Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptide Conjugates Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptide Conjugates Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptide Conjugates Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptide Conjugates Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptide Conjugates Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptide Conjugates Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptide Conjugates Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptide Conjugates Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptide Conjugates Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptide Conjugates Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptide Conjugates Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptide Conjugates Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptide Conjugates Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptide Conjugates Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst